Key changes to treatment of multidrug- and rifampicin-resistant tuberculosis (MDR/RR-TB)

Courtesy: Dr Vidya Devarajan and Dr Rohit Vashisht

It appears that linzolid, bedaquiline and clofazimine have superceded injectables and ethionamide.